Synthesis Business Unit
Chandra Chereddi leads the Synthesis Business Unit at Laurus Labs Inc., India. Prior to this current assignment at Laurus Labs, Chandra headed the Project Management division for all scientific projects at the Laurus R&D center. Before joining Laurus, Chandra worked for McKinsey & Company in their India office as a member of the healthcare practice, where he advised major generic pharmaceutical companies in matters related to marketing and sales, international growth and supply chain efficiencies. Prior to his stint at McKinsey, Chandra worked for Google Inc. as a software engineer in Google’s Mountain View, California office. Chandra holds a BE from the College of Engineering, Osmania University, Hyderabad, an MS from the University of Illinois at Urbana-Champaign, and an MBA from the Indian School of Business, Hyderabad.
In addition to his responsibilities with the Synthesis Business Unit, Chandra also heads the development of growth and risk-mitigation strategies for Laurus Labs.
V V Ravi Kumar,
For the past 23 years. Ravi has been garnering experience in Finance, IT and Supply Chain management. He has extensive professional experience in the pharmaceutical industry and working knowledge in negotiating mergers and acquisitions and joint venture management on a global level.
Ravi is a part of the senior management team that transformed M/s Matrix Laboratories into a major pharmaceutical company.
Dr. Venkata Vadlapatla,
VP Operations &,
Venkat has more than 26 years of experience in the pharmaceutical industry, including 8 years at IDT Australia Ltd and 10 years at Frontage laboratories Inc. in the USA. He brings diverse experience in research and development, cGMP manufacturing, operations, project management and sourcing to his position at LSI. Dr. Vadlapatla received his MS in Chemistry and PhD in Pharmaceutical Chemistry from Andhra University, India, as well as a PhD in Chemistry from University of Queensland, Australia.
Charles leads our scientific team and is responsible for the delivery of chemistry and analytical development. He is a proven scientific leader with almost 20 years of experience in chemistry and research in the US and UK. Prior to joining Laurus Synthesis, Charles was with Albany Molecular Research (AMRI), where he was most recently the Director of Chemical Development. Charles has a BSc in Chemistry and a PhD in Synthetic Organic Chemistry from the University of Edinburgh.
Board of Directors
The Laurus Synthesis Board of Directors is comprised of pharmaceutical industry leaders with global drug development, discovery and commercialization experience. These individuals have led pharmaceutical manufacturing and drug development organizations on three continents and are dedicated to ensuring the long-term success of Laurus Synthesis.